Doctor profile · Federal record
Dr. George Reeder, MD
Pulmonary Disease Physician (CMS: Pulmonary Disease) · Internal Medicine Physician · Critical Care Medicine (Internal Medicine) Physician · Salisbury, MD
- NPI 1760472153
- Accepts Medicare
- MIPS 79.5 / 100 · 2023
- 28 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
100 E Carroll St
Salisbury, MD 218015422
(410) 543-7722
fax (410) 543-7725
Credentials & registration
- NPI registered
- October 2005 — 21 yrs on file
- Profile last updated
- April 24, 2014
- Year of graduation
- 1998 — 28 yrs since
- Specialty taxonomy
- 207RP1001X — NUCC code
- State license (1)
- Maryland #D0062670
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1760472153. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
6,097
Distinct HCPCS
10
Medicare allowed
$562,388
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0517 |
Injection, benralizumab, 1 mg | 2,130 | 17 | $166 | |
94729 |
Test to examine how well the lungs exchange gases | 659 | 648 | $9 | |
94726 |
Test to determine lung volumes using sensors | 646 | 635 | $12 | |
94375 |
Test to measure rate of airflow | 642 | 609 | $14 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 405 | 328 | $130 | |
96372 |
Injection of drug or substance under skin or into muscle | 281 | 46 | $15 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 239 | 203 | $182 | |
94060 |
Test to measure expiratory airflow and volume changes before and after medication administration | 216 | 215 | $10 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 205 | 180 | $92 | |
95810 |
Sleep study in sleep lab (6 years or older) | 173 | 171 | $120 |
In context: peer comparison
Among 2 peers in this city , average services per provider: 222. This provider delivers 27× the peer median.Open Payments
Industry payments received
All-time total
$474
Transactions
16
Manufacturers
8
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| GENZYME CORPORATION | 5 | $191.18 | |
| Amgen Inc. | 3 | $87.07 | |
| Insmed, Inc. | 2 | $57.64 | |
| GlaxoSmithKline, LLC. | 2 | $52.87 | |
| PFIZER INC. | 1 | $26.22 | |
| Novartis Pharmaceuticals Corporation | 1 | $22.50 | |
| Grifols USA, LLC | 1 | $18.23 | |
| Electromed, Inc. | 1 | $17.89 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,913
Patients
960
Total drug cost
$1,686,013
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) | Brand | 586 | 162 | $739,390 |
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 456 | 150 | $21,491 |
| Montelukast Sodium | Generic | 313 | 93 | $6,305 |
| Breo Ellipta (Fluticasone/Vilanterol) | Brand | 216 | 64 | $177,340 |
| Incruse Ellipta (Umeclidinium Bromide) | Brand | 178 | 61 | $146,854 |
| Prednisone | Generic | 178 | 74 | $1,067 |
| Spiriva Respimat (Tiotropium Bromide) | Brand | 177 | 52 | $188,025 |
| Anoro Ellipta (Umeclidinium Brm/Vilanterol Tr) | Brand | 159 | 55 | $166,790 |
| Fluticasone Propionate | Generic | 152 | 62 | $3,399 |
| Ventolin Hfa (Albuterol Sulfate) | Brand | 138 | 52 | $13,640 |
Hospital affiliations
Frequently asked questions
What is Dr. George Reeder's medical specialty?
Dr. George Reeder practices Pulmonary Disease Physician in Salisbury, MD.
Where does Dr. George Reeder practice?
Dr. George Reeder practices at 100 E Carroll St, Salisbury, MD 218015422. Office phone: 4105437722.
What is Dr. George Reeder's NPI?
Dr. George Reeder's National Provider Identifier (NPI) is 1760472153, issued by NPPES.
Does Dr. George Reeder accept Medicare assignment?
Yes. Dr. George Reeder accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. George Reeder commonly perform?
Top Medicare-reported procedures in 2023: Injection, benralizumab, 1 mg (HCPCS J0517); Test to examine how well the lungs exchange gases (HCPCS 94729); Test to determine lung volumes using sensors (HCPCS 94726). Source: CMS Medicare Physician & Other Practitioners file.